Parnax Lab

Parnax Lab Current Liabilities

The Current Liabilities of Parnax Lab (506128.BO) as of Nov 18, 2026 is 743.34 M INR. In the previous year, Current Liabilities was 833.27 M INR — a change of -10.79% (lower).

Current Liabilities

743.34 MINR

YoY

-10.79%

Last updated:

Current Liabilities of Parnax Lab is 2025 743.34 M INR. Current Liabilities of Parnax Lab was 2024 833.27 M INR. It decreases by -10.79% lower compared to the previous year.

The Parnax Lab Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
371.91 M INR
Jan 1, 2019
362.89 M INR
Jan 1, 2020
524.43 M INR
Jan 1, 2021
543.74 M INR
Jan 1, 2022
809.77 M INR
Jan 1, 2023
630.42 M INR
Jan 1, 2024
833.27 M INR
Jan 1, 2025
743.34 M INR
The Parnax Lab Current Liabilities history
YEARCurrent LiabilitiesYoY
743.34 MINR-10.79%
833.27 MINR+32.18%
630.42 MINR-22.15%
809.77 MINR+48.93%
543.74 MINR+3.68%
524.43 MINR+44.51%
362.89 MINR-2.43%
371.91 MINR-35.53%
576.86 MINR+8.55%
531.41 MINR-0.31%
533.08 MINR-6.72%
571.47 MINR+129.51%
249.00 MINR-15.74%
295.50 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Current Liabilities of Parnax Lab is 743.34 M INR in 2025.

Current Liabilities of Parnax Lab changed from 833.27 M INR to 743.34 M INR, representing a -10.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Parnax Lab

All Key Metrics — Parnax Lab